Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04LJH
|
||||
Former ID |
DIB018228
|
||||
Drug Name |
[3H]A-585539
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540592] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H21N4+
|
||||
InChI |
InChI=1S/C17H21N4/c1-21(2)12-14-10-15(21)11-20(14)17-9-8-16(18-19-17)13-6-4-3-5-7-13/h3-9,14-15H,10-12H2,1-2H3/q+1
|
||||
InChIKey |
AKMKIDQMKPFYDJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholine receptor protein, alpha-7 chain | Target Info | Agonist | [529116] | |
References | |||||
Ref 529116 | [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain. J Pharmacol Exp Ther. 2008 Jan;324(1):179-87. Epub 2007 Oct 24. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.